310 results on '"Barber, Katie E"'
Search Results
2. Risk factors for development of initial Clostridioides difficile infection
3. High-dose amphotericin: yay or nay? A case series and literature review
4. A Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in 2022
5. Impact of Obesity in Patients with Candida Bloodstream Infections: A Retrospective Cohort Study
6. When More Is Still Not Enough: A Case of Ceftazidime-Avibactam Resistance in a Burn Patient
7. Counting the Cost of Daptomycin Versus Vancomycin in Hospitalized Patients: A Cost Minimization Analysis.
8. Antifungal resistance, combinations and pipeline: oh my!
9. Effect of fish oil supplement administration method on tolerability and adherence: a randomized pilot clinical trial
10. Treatment decisions in VRE bacteraemia: a survey of infectious diseases pharmacists
11. Implementation of Twitter and Google Voice to simulate a pharmacy resident’s day on-call for third-year pharmacy students
12. Evaluation of an Antifungal Stewardship Initiative Targeting Micafungin at an Academic Medical Center
13. Comparative Genomics of Streptococcus oralis Identifies Large Scale Homologous Recombination and a Genetic Variant Associated with Infection
14. Time–Kill Analysis of Ceftolozane/Tazobactam Efficacy Against Mucoid Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients
15. Intravenous Vancomycin Dosing in the Elderly: A Focus on Clinical Issues and Practical Application
16. ABCG2 Polymorphisms and Predictive Fluoroquinolone Phototoxicity in Nondomestic Felids
17. Analysis of the Clinical Impact of the BioFire FilmArray Meningitis Encephalitis Panel on Antimicrobial Use and Duration of Therapy at an Academic Medical Center
18. A Baker’s Dozen of Top Antimicrobial Stewardship Intervention Publications in Non–Hospital Care Settings in 2021
19. Rethinking residency recruitment, application, and interview processes to benefit applicants and programs long-term
20. A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections
21. Newest lipoglycopeptides for the management of acute bacterial skin and skin structure infections
22. Risk Factors for Failure in Complicated Intraabdominal Infections
23. Impact of piperacillin-tazobactam shortage on meropenem use: implications for antimicrobial stewardship programs
24. Evaluation of Pharmacodynamic Interactions Between Telavancin and Aztreonam or Piperacillin/Tazobactam Against Pseudomonas aeruginosa, Escherichia coli and Methicillin-Resistant Staphylococcus aureus
25. Evaluation of pharmacy residency recruitment and interview processes during the COVID‐19 pandemic (2020‐2021 application cycle)
26. Comparative genomics ofStreptococcus oralisidentifies large scale homologous recombination and a genetic variant associated with infection
27. Ceftaroline for the treatment of methicillin-resistant Staphylococcus aureus bacteremia
28. Variation Among Infectious Diseases Pharmacists for the Treatment of Staphylococcus aureus Bacteremia.
29. Evaluation of pharmacy residency recruitment and interview processes during the COVID‐19 pandemic (2020‐2021 application cycle).
30. Diabetic foot infections: A microbiologic review
31. Intravenous versus Oral Step-Down for the Treatment of Staphylococcus aureus Bacteremia in a Pediatric Population
32. Approach to fever in patients with neutropenia: a review of diagnosis and management
33. High-Dose Daptomycin Therapy for Staphylococcal Endocarditis and When to Apply It
34. Observation of “Seesaw Effect” with Vancomycin, Teicoplanin, Daptomycin and Ceftaroline in 150 Unique MRSA Strains
35. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid
36. Activities to enhance introductory pharmacy practice experiences
37. Linezolid for the Treatment of Urinary Tract Infections Caused by Vancomycin-Resistant Enterococci
38. β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium
39. Comment on: Failure of combination therapy with daptomycin and synergistic ceftriaxone for enterococcal endocarditis
40. Therapeutic options for vancomycin-resistant enterococcal bacteremia
41. Ceftobiprole and ampicillin increase daptomycin susceptibility of daptomycin-susceptible and -resistant VRE
42. The combination of ceftaroline plus daptomycin allows for therapeutic de-escalation and daptomycin sparing against MRSA
43. Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia
44. Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in Non–Hospital Care Settings in 2021.
45. Variation Among Infectious Diseases Pharmacists for the Treatment of Staphylococcus aureus Bacteremia
46. Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant Enterococcus faecium and faecalis
47. Optimizing rapid diagnostics and diagnostic stewardship in Gram‐negative bacteremia
48. sj-pdf-1-jpp-10.1177_08971900211038864 – Supplemental Material for Variation Among Infectious Diseases Pharmacists for the Treatment of Staphylococcus aureus Bacteremia
49. Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypes
50. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.